Evaluation du site ichgcp.net
ICH GCP - ICH E6 (R3) Guideline on good clinical practice (GCP)
Généré le 07 Mars 2026 10:15
Vieilles statistiques? UPDATE !
Le score est de 67/100
Optimisation du contenu
Titre
ICH GCP - ICH E6 (R3) Guideline on good clinical practice (GCP)
Longueur : 63
Parfait, votre titre contient entre 10 et 70 caractères.
Description
ICH GCP - GOOD CLINICAL PRACTICE (GCP) E6(R3) Step 5. Date for coming into effect 23 July 2025. ICH E6(R3) introduces innovative provisions designed to apply across various types and settings of clinical trials, ensuring continued relevance in the face of ongoing technological and methodological advancements. This guideline provides a new language to facilitate innovations in clinical trial design, technology, and operational approaches. It encourages a risk-based and proportionate approach to conducting clinical trials, promoting fit-for-purpose solutions. It fosters transparency through clinical trial registration and result reporting and offers additional guidance to enhance the informed consent process.
Longueur : 717
Idéalement, votre balise META description devrait contenir entre 70 et 160 caractères (espaces compris). Utilisez cet outil gratuit pour calculer la longueur du texte.
Mots-clefs
ICH GCP - good clinical practice, GOOD CLINICAL PRACTICE (GCP) E6(R3) Step 5, ICH E6(R1), ICH E6(R2), ICH GCP, ICH GCP E6(R2), 23 January 2025, Date for coming into effect 23 July 2025, decentralised, real-world, pragmatic, investigator, sponsor, protocol, investigator's brochure, trial design, safety reporting, informed consent, statistics, ethics committee, clinical study/trial report, clinical trials, innovation, design., ICH GCP
Bien, votre page contient une balise META keywords.
Propriétés Open Graph
Bien, cette page profite des balises META Open Graph.
| Propriété | Contenu |
|---|---|
| title | ICH harmonised guideline: ICH E6 (R3) Guideline on good clinical practice (GCP)_main |
| type | article |
| url | https://ichgcp.net/ich-harmonised-guideline-ich-e6-r3-guideline-on-good-clinical-practice-gcp-main |
| description | ... |
| site_name | ICHGCP |
| locale | en |
Niveaux de titre
| H1 | H2 | H3 | H4 | H5 | H6 |
| 1 | 6 | 6 | 0 | 0 | 0 |
- [H1] ICH E6 (R3) Guideline on good clinical practice (GCP)
- [H2] Clinical Research News
- [H2] Upcoming Clinical Trials
- [H2] Clinical Research Jobs
- [H2] Sponsors and Collaborators
- [H2] Medical Conditions
- [H2] Drug Interventions
- [H3] International Conference on Harmonisation of technical requirements for registration of pharmaceuticals for human use
- [H3] GOOD CLINICAL PRACTICE (GCP) E6(R3) Step 5
- [H3] 23 January 2025. Date for coming into effect 23 July 2025
- [H3] I. INTRODUCTION II. PRINCIPLES OF ICH GCP III. ANNEX 1 1. INSTITUTIONAL REVIEW BOARD/INDEPENDENT ETHICS COMMITTEE (IRB/IEC) 2. INVESTIGATOR 3. SPONSOR 4. DATA GOVERNANCE – INVESTIGATOR AND SPONSOR Appendix A. INVESTIGATOR’S BROCHURE Appendix B. CLINICAL TRIAL PROTOCOL AND PROTOCOL AMENDMENT(S) Appendix C. ESSENTIAL RECORDS FOR THE CONDUCT OF A CLINICAL TRIAL GLOSSARY
- [H3] Something went wrong!
- [H3] Something went wrong!
Images
Nous avons trouvé 12 image(s) sur cette page Web.
11 attribut(s) alt sont vides ou manquants. Ajouter un texte alternatif permet aux moteurs de recherche de mieux comprendre le contenu de vos images.
Ratio texte/HTML
Ratio : 19%
Bien, le ratio de cette page texte/HTML est supérieur à 15, mais inférieur à 25 pour cent.
Flash
Parfait, aucun contenu FLASH n'a été détecté sur cette page.
Iframe
Génial, il n'y a pas d'Iframes détectés sur cette page.
Liens
Réécriture d'URLs
Bien. Vos liens sont optimisés!
Tiret bas dans les URLs
Nous avons détectés des soulignements dans vos URLs. Vous devriez plutôt utiliser des tirets pour optimiser votre référencement.
Liens dans la page
Nous avons trouvé un total de 155 lien(s) dont 0 lien(s) vers des fichiers
| Texte d'ancre | Type | Juice |
|---|---|---|
| ICH GCP (De) | Interne | Passing Juice |
| ICH GCP (En) | Interne | Passing Juice |
| ICH GCP (Es) | Interne | Passing Juice |
| ICH GCP (Fr) | Interne | Passing Juice |
| ICH GCP (It) | Interne | Passing Juice |
| ICH GCP (Pt) | Interne | Passing Juice |
| ICH GCP (Ru) | Interne | Passing Juice |
| USA (FDA) | Interne | Passing Juice |
| UK (MHRA) | Interne | Passing Juice |
| AUSTRALIA (NHMRC) | Interne | Passing Juice |
| JAPAN (PMDA) | Interne | Passing Juice |
| EU (EMA) | Interne | Passing Juice |
| CRO List | Interne | Passing Juice |
| US Clinical Trials Registry | Interne | Passing Juice |
| EU Clinical Trials Registry | Interne | Passing Juice |
| Pharmaceutical Companies | Interne | Passing Juice |
| Clinical Research Labs | Interne | Passing Juice |
| Service Companies | Interne | Passing Juice |
| Clinical Research Events | Interne | Passing Juice |
| Publications | Interne | Passing Juice |
| Researchers | Interne | Passing Juice |
| Jobs | Interne | Passing Juice |
| Publications | Interne | Passing Juice |
| News | Interne | Passing Juice |
| I. INTRODUCTION | Interne | Passing Juice |
| II. PRINCIPLES OF ICH GCP | Interne | Passing Juice |
| III. ANNEX 1 | Interne | Passing Juice |
| 1. INSTITUTIONAL REVIEW BOARD/INDEPENDENT ETHICS COMMITTEE (IRB/IEC) | Interne | Passing Juice |
| 2. INVESTIGATOR | Interne | Passing Juice |
| 3. SPONSOR | Interne | Passing Juice |
| 4. DATA GOVERNANCE – INVESTIGATOR AND SPONSOR | Interne | Passing Juice |
| Appendix A. INVESTIGATOR’S BROCHURE | Interne | Passing Juice |
| Appendix B. CLINICAL TRIAL PROTOCOL AND PROTOCOL AMENDMENT(S) | Interne | Passing Juice |
| Appendix C. ESSENTIAL RECORDS FOR THE CONDUCT OF A CLINICAL TRIAL | Interne | Passing Juice |
| GLOSSARY | Interne | Passing Juice |
| - | Interne | Passing Juice |
| - | Interne | Passing Juice |
| - | Interne | Passing Juice |
| - | Interne | Passing Juice |
| - | Interne | Passing Juice |
| - | Interne | Passing Juice |
| - | Interne | Passing Juice |
| Hepatic and Splenic Microcirculatory Perfusion for Ruling Out High-Risk Varices in Patients With Hepatitis B-Related Cirrhosis | Interne | Passing Juice |
| Sensory Substitution and Brain Plasticity Following Vision Loss (SenSubMRI) | Interne | Passing Juice |
| Exercise Training Effects on Muscle Function in Adults With Mitochondrial Myopathy (MM-EX) | Interne | Passing Juice |
| The Effect of the Health Belief Model-Based Education Given to Mothers of Children Aged 9-15 on HPV Knowledge Level and Child Vaccination | Interne | Passing Juice |
| Assessing the Efficacy and Safety of Photobiomodulation for the Treatment of Pruritus | Interne | Passing Juice |
| GLUEPED2024: Study on the Use of Peripheral Venous Catheters in Pediatric Patients With Emergency Room Access. | Interne | Passing Juice |
| Digital Storytelling and Mother's Knowledge and Attitudes Towards Newborn Screning | Interne | Passing Juice |
| Concomitant PFA Bsaed PVI Plus LAAC - a Prospective Registry Study (COCONUT_2) | Interne | Passing Juice |
| Tranexamic Acid Dose and Remifentanil Titration in Septorhinoplasty | Interne | Passing Juice |
| OPTIMISE-CKD Study_Dapagliflozin Effectiveness in CKD | Interne | Passing Juice |
| Incidence and Evolution of Heart-lung Interaction in Acute Respiratory Distress Syndrome (IVOLIA) | Interne | Passing Juice |
| A Study of BT5528 in Patients With Metastatic Pancreatic Ductal Adenocarcinoma (PDAC) | Interne | Passing Juice |
| PSI | Interne | Passing Juice |
| PPD | Interne | Passing Juice |
| Medpace | Interne | Passing Juice |
| Parexel | Interne | Passing Juice |
| Charles River Laboratories | Interne | Passing Juice |
| Fortrea | Interne | Passing Juice |
| Worldwide Clinical Trials | Interne | Passing Juice |
| Eurofins Optimed | Interne | Passing Juice |
| Ergomed | Interne | Passing Juice |
| Syneos Health | Interne | Passing Juice |
| IQVIA | Interne | Passing Juice |
| More jobs | Interne | Passing Juice |
| Assiut University | Interne | Passing Juice |
| Cairo University | Interne | Passing Juice |
| GlaxoSmithKline | Interne | Passing Juice |
| National Cancer Institute (NCI) | Interne | Passing Juice |
| Assistance Publique - Hôpitaux de Paris | Interne | Passing Juice |
| AstraZeneca | Interne | Passing Juice |
| Pfizer | Interne | Passing Juice |
| Mayo Clinic | Interne | Passing Juice |
| M.D. Anderson Cancer Center | Interne | Passing Juice |
| Novartis Pharmaceuticals | Interne | Passing Juice |
| National Taiwan University Hospital | Interne | Passing Juice |
| Massachusetts General Hospital | Interne | Passing Juice |
| National Institute of Allergy and Infectious Diseases (NIAID) | Interne | Passing Juice |
| Boehringer Ingelheim | Interne | Passing Juice |
| Merck Sharp & Dohme LLC | Interne | Passing Juice |
| University of California, San Francisco | Interne | Passing Juice |
| Stanford University | Interne | Passing Juice |
| Hoffmann-La Roche | Interne | Passing Juice |
| Eli Lilly and Company | Interne | Passing Juice |
| Duke University | Interne | Passing Juice |
| View Full List | Interne | Passing Juice |
| Breast Cancer | Interne | Passing Juice |
| Obesity | Interne | Passing Juice |
| Stroke | Interne | Passing Juice |
| Hypertension | Interne | Passing Juice |
| Depression | Interne | Passing Juice |
| Pain | Interne | Passing Juice |
| Prostate Cancer | Interne | Passing Juice |
| HIV Infections | Interne | Passing Juice |
| Cancer | Interne | Passing Juice |
| Coronary Artery Disease | Interne | Passing Juice |
| Heart Failure | Interne | Passing Juice |
| Asthma | Interne | Passing Juice |
| Colorectal Cancer | Interne | Passing Juice |
| Diabetes Mellitus, Type 2 | Interne | Passing Juice |
| Anxiety | Interne | Passing Juice |
| Lung Cancer | Interne | Passing Juice |
| Cardiovascular Diseases | Interne | Passing Juice |
| Diabetes | Interne | Passing Juice |
| COVID-19 | Interne | Passing Juice |
| Schizophrenia | Interne | Passing Juice |
| View Full List | Interne | Passing Juice |
| Cyclophosphamide | Interne | Passing Juice |
| Cisplatin | Interne | Passing Juice |
| Carboplatin | Interne | Passing Juice |
| Paclitaxel | Interne | Passing Juice |
| Dexamethasone | Interne | Passing Juice |
| Docetaxel | Interne | Passing Juice |
| Gemcitabine | Interne | Passing Juice |
| Bevacizumab | Interne | Passing Juice |
| Metformin | Interne | Passing Juice |
| Pembrolizumab | Interne | Passing Juice |
| Capecitabine | Interne | Passing Juice |
| Prednisone | Interne | Passing Juice |
| Oxaliplatin | Interne | Passing Juice |
| Methotrexate | Interne | Passing Juice |
| Rituximab | Interne | Passing Juice |
| Etoposide | Interne | Passing Juice |
| Dexmedetomidine | Interne | Passing Juice |
| Fludarabine | Interne | Passing Juice |
| Cytarabine | Interne | Passing Juice |
| Propofol | Interne | Passing Juice |
| View Full List | Interne | Passing Juice |
| GLOBAL (ICH GCP) | Interne | Passing Juice |
| EU (EMA) | Interne | Passing Juice |
| Jobs | Interne | Passing Juice |
| About us / Our mission | Interne | Passing Juice |
| Sitemap | Interne | Passing Juice |
| Contact us | Interne | Passing Juice |
| RSS feed | Interne | Passing Juice |
| Privacy Policy | Interne | Passing Juice |
| Disclaimer | Interne | Passing Juice |
| Dansk | Interne | Passing Juice |
| Deutsch | Interne | Passing Juice |
| Español | Interne | Passing Juice |
| Français | Interne | Passing Juice |
| Italiano | Interne | Passing Juice |
| Magyar | Interne | Passing Juice |
| Nederlands | Interne | Passing Juice |
| Norsk | Interne | Passing Juice |
| Polski | Interne | Passing Juice |
| Português | Interne | Passing Juice |
| Suomi | Interne | Passing Juice |
| Svenska | Interne | Passing Juice |
| Čeština | Interne | Passing Juice |
| Русский | Interne | Passing Juice |
| 日本語 | Interne | Passing Juice |
| 简体中文 | Interne | Passing Juice |
| 한국어 | Interne | Passing Juice |
Mots-clefs
Nuage de mots-clefs
recruiting university study ich trials clinical states research gcp united
Cohérence des mots-clefs
| Mot-clef | Contenu | Titre | Mots-clefs | Description | Niveaux de titre |
|---|---|---|---|---|---|
| clinical | 20 |  |
|
|
|
| gcp | 14 | |
|
|
|
| ich | 13 | |
|
|
|
| recruiting | 13 |  |
|
|
|
| trials | 10 | |
|
|
|
Ergonomie
Url
Domaine : ichgcp.net
Longueur : 10
Favicon
Génial, votre site web dispose d'un favicon.
Imprimabilité
Aucun style CSS pour optimiser l'impression n'a pu être trouvé.
Langue
Bien. Votre langue est : en.
Dublin Core
Cette page ne profite pas des métadonnées Dublin Core.
Document
Doctype
HTML 5
Encodage
Parfait. Votre charset est UTF-8.
Validité W3C
Erreurs : 0
Avertissements : 0
E-mail confidentialité
Attention! Au moins une adresse e-mail a été trouvée en texte clair. Utilisez une protection anti-spam gratuite pour cacher vos e-mails aux spammeurs.
HTML obsolètes
Génial! Nous n'avons pas trouvé de balises HTML obsolètes dans votre code.
Astuces vitesse
|
Excellent, votre site n'utilise pas de tableaux imbriqués. |
|
Mauvais, votre site web utilise des styles css inline. |
|
Génial, votre site web contient peu de fichiers CSS. |
|
Mauvais, votre site web contient trop de fichiers javascript (plus de 6). |
|
Parfait : votre site tire parti de gzip. |
Mobile
Optimisation mobile
|
Icône Apple |
|
Méta tags viewport |
|
Contenu FLASH |
Optimisation
Sitemap XML
Votre site web dispose d’une sitemap XML, ce qui est optimal.
| https://ichgcp.net/sitemap.xml |
Robots.txt
https://ichgcp.net/robots.txt
Votre site dispose d’un fichier robots.txt, ce qui est optimal.
Mesures d'audience
Votre site web dispose d’une outil d'analytics, ce qui est optimal.
Google Analytics |
PageSpeed Insights
Dispositif
Les catégories
Free SEO Testing Tool
Free SEO Testing Tool est un outil gratuit de référencement qui vous aidera à analyser vos pages web